Track APLS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
APLS - Apellis Pharmaceuticals Inc (APLS) has a earnings per share of $0.15, up 120.3% over the past year.
Latest EPS (Actual)
$0.15
Beat Rate
62.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.36 | $0.15 | Beat | +141.67% |
| Mar 2026 | -$0.38 | -$0.47 | Miss | -24.01% |
| Oct 2025 | $0.94 | $1.67 | Beat | +77.66% |
| Jul 2025 | -$0.47 | -$0.33 | Beat | +29.79% |
| May 2025 | -$0.35 | -$0.74 | Miss | -111.43% |
| Feb 2025 | -$0.40 | -$0.29 | Beat | +27.84% |
| Nov 2024 | -$0.27 | -$0.46 | Miss | -70.37% |
| Aug 2024 | -$0.32 | -$0.29 | Beat | +9.38% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.